Norbrook Laboratories

Since its foundation in 1968, Norbrook Laboratories Ltd has grown to be one of the world's leading pharmaceutical companies. With manufacturing facilities on four continents and sales and marketing offices in over 30 countries, the company exports to more than 120 countries worldwide.
The Company has a particularly large veterinary division and is the only company in the world licenced by the food and drug administration of the United States to manufacture sterile injections for veterinary use outside the USA and import same for sale in USA territory. The Company has four divisions, bulk pharmaceutical synthesis division which includes synthetic penicillins, a wide range of antibiotic steroids, and hormones and anthelmintics. The Company is almost self-contained in its raw material production and produces many intermediates for the pharmaceutical industry.

The Company's finished dose forum division produces sterile injectables for both medical and veterinary use. It has facilities to produce tablets, capsules, aerosols, creams, sterile injections of solutions, suspensions and powders. All to the standards of Good Manufacturing Practice and for export world wide including Europe, the US and Japan.

The Company has a heavy commitment to chemical process development. It has invested over £80 Million within the last 5 years in the synthesis of complicated molecules

Research and Development is of major importance - over 10% of the company's turnover is annually invested in research and development of new products. There is a strong pipeline and the Company has filed a number of patents each year and obtained marketing authorisations worldwide to a level that equates with any of its multinational competitors.

Its production facilities in Ireland, North and South are housed on over 100 acres of land with 40 acres covered employing in excess of 1500 people.